Navigation Links
Increased Capital Funding for Unisense FertiliTech A/S Will Help Meet Demand for New Assisted Reproduction Device
Date:12/16/2009

(Aarhus, Denmark, December 14, 2009) Unisense FertiliTech A/S has received a further 1.6 million Euro in capital funding to scale up production and support of the EmbryoScope™ Embryo Monitoring System in order to meet the rapidly growing demand for this promising new technology. The capital was invested by LD Pensions and Unisense A/S that continue to own each about 50% of the company.

Aarhus, Denmark (PRWEB) December 16, 2009 -- Unisense FertiliTech A/S has received a further 1.6 million Euro in capital funding to scale up production and support of the EmbryoScope™ Embryo Monitoring System in order to meet the rapidly growing demand for this promising new technology. The capital was invested by LD Pensions and Unisense A/S that continue to own each about 50% of the company.

During IVF treatment, multiple oocytes are removed from the patient and fertilized in-vitro. The resulting fertilized eggs are allowed to develop for a period of 2 to 5 days, before the embryologist must select the best potential embryo or embryos to transfer back to the patient. Ideally, a single embryo resulting in a single pregnancy is optimal as multiple pregnancies present risks to both maternal and fetal health.

A major challenge for the embryologist is determining which embryos have the best potential to create a single healthy baby. The EmbryoScope® Embryo Monitoring System allows uninterrupted time-lapse observation of embryo development in a stable controlled incubation environment. Embryo quality parameters can be assessed and reviewed without the potentially damaging effects of removing the embryo from a stable controlled environment.

CEO Jens Gundersen says they are encouraged with the overwhelming response to the initial sales launch of the instrument, and that with the additional capital, FertiliTech will be able to scale up production to meet the demands of the rapidly expanding interest for the EmbryoScope® Embryo monitoring system.

Unisense FertiliTech A/S is a Danish company which was founded in 2003, as a daughter company of Unisense A/S. The company develops and manufactures instruments and analysis solutions to facilitate in-vitro Fertilization. The company is highly research oriented and is currently involved in various international research projects involving improved embryo selection and analysis, embryo respiration and stem cell research.

Contact Person:
Francesca Bahr
Sales and Marketing Manager
Unisense FertiliTech A/S
Phone Number +45 89449525
Mobile Phone: +45 40255538

Jens K. Gundersen
CEO
+45 21601675

Email Address fab (at) fertilitech (dot) com
Website URL http://www.fertilitech.com

###

Read the full story at http://www.prweb.com/releases/2009/12/prweb3339374.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Increased distance to physician associated with thicker skin cancer at diagnosis
2. Methamphetamine study suggests increased risk for HIV transmission
3. New Alzheimers findings: High stress and genetic risk factor lead to increased memory decline
4. Minorities more likely to have sleep durations associated with increased mortality
5. Teens who see more smoking in movies may have increased risk of becoming established smokers
6. Study shows adverse drug events reported to the FDA have significantly increased
7. New Case Study Details How an Illinois Hospital Created a Safe Lifting Team that Dramatically Reduced Injuries, Increased Staff Satisfaction
8. Maternal depression and controlling behavior associated with increased stress response in infants
9. BioProcessors Launches SimCell(TM) Services to Meet Increased Customer Demand
10. Both short and long sleep is associated with increased mortality
11. New Study Shows Lower Costs, Increased Consumer Engagement in Account-Based Health Plans
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Increased Capital Funding for Unisense FertiliTech A/S Will Help Meet Demand for New Assisted Reproduction Device 
(Date:5/3/2016)... ... 03, 2016 , ... Diagnotes, a leader in digital healthcare ... hospital system in South Carolina, to provide its secure mobile communication platform. , ... communication, drives workflow efficiencies and improves provider and patient satisfaction,” said Dr. Todd ...
(Date:5/3/2016)... ... May 03, 2016 , ... Park Cities Pet Sitter has openings ... to the 75204, 75205, 75206, 75209, 75219, 75220, 75225, 75229, 75230, 75231 and 75235 ... Hollow, North Dallas, Plano, Preston Hollow and Park Cities areas of the Metroplex. ...
(Date:5/3/2016)... ... May 03, 2016 , ... ... technology (IT) solutions and digital consulting services to the federal government, has been ... Indefinite Delivery / Indefinite Quantity (ID/IQ) contract in support of the U.S. Army ...
(Date:5/3/2016)... , ... May 03, 2016 ... ... of Microsoft secure remote access connectivity solutions, today announced the new SecureAccess ... Microsoft DirectAccess. The new Celestix SecureAccess release will enable organizations to get ...
(Date:5/3/2016)... , ... May 03, 2016 , ... Dave Newberry, broker/owner ... Interim Care Center (PICC) annual fundraiser luncheon on Friday, May 20. “We have ... the smallest victims of drug abuse,” said Newberry. , PICC is a local Kent, ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... May 3, 2016 ... dass sie einen entscheidenden Meilenstein durch diese ... Aufruf zum Handeln, um Patientenresultate  bei Verdauungs- ... zu Fortschritten im Verständnis der Hepatischen Enzephalopathie ... Bewusstsein für Hepatische Enzephalopathie in der Öffentlichkeit ...
(Date:5/2/2016)... Mass. , May 2, 2016  While nearly ... that osteoporosis can have on their health, only about ...   according to the results of a new survey ... To mark the start of National Osteoporosis Month, Hologic ... health, which affects nearly 56 million Americans. ...
(Date:4/29/2016)... 29, 2016 ReportsnReports.com adds ... market research report that provides an overview of ... at various stages, therapeutics assessment by drug target, ... and molecule type, along with latest updates, and ... key players involved in the therapeutic development for ...
Breaking Medicine Technology: